Previous issue | Volume 94 | ESPE2021

59th Annual ESPE (ESPE 2021 Online)

22 Sep 2021 - 26 Sep 2021

Card image cap
The 59th ESPE Annual Meeting will now be held online in September 2021.

ePoster Category 1

Fat, Metabolism and Obesity A

Efficacy and Safety of Setmelanotide in Individuals With Obesity Due to POMC or LEPR Deficiency: Phase 3 Results From Pivotal and Supplemental Cohorts
1Wellcome-MRC Institute of Metabolic Science and NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom; 2Pediatric Endocrinology, University of Florida, Gainesville, USA; 3Rhythm Pharmaceuticals, Inc., Boston, USA; 4Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, USA
Metabolomics in early life and the association with body composition at age 2 years
1Erasmus University Medical Center/Sophia Children’s Hospital, Rotterdam, Netherlands; 2University of Cambridge, Cambridge, United Kingdom; 3Royal Holloway University of London, London, United Kingdom; 4Technical University of Denmark, Lyngby, Denmark; 5Clinical-Microbiomics A/S, Copenhagen, Denmark
High prevalence of undiagnosed metabolic dysfunction among children and adolescents with obesity in China
The Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China
The possible association of the apoptotic marker APO1/Fas with predisposition to metabolic syndrome and mean platelet volume in children
1Division of Paediatric Endocrinology and Diabetes, Department of Paediatrics, University of Patras School of Medicine, Patras, Greece, Patras, Greece; 2Laboratory of Biology and Biochemistry, Faculty of Health Sciences, Department of Nursing, University of Peloponnese, Tripoli, Greece, Tripoli, Greece; 3Kapodistrian University of Athens Medical School, Aeginition Hospital, Department of Biopathology and Clinical Microbiology, Athens, Greece, Athens, Greece; 4Department of Statistics and Insurance Science, Faculty of Finance and Statistics, University of Piraeus, Athens, Greece, Athens, Greece
Serum endocan as a predictive biomarker of cardiovascular risk in obese pediatric patients
1Department of Human Pathology of Adulthood and Childhood, University of Messina, Messina, Italy; 2Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
Liraglutide for the Management of Childhood Obesity
Alder Hey Children’s Hospital, Liverpool, United Kingdom